161 related articles for article (PubMed ID: 1929956)
1. Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease.
Sakamoto T; Murata T; Inomata H
Arch Ophthalmol; 1991 Sep; 109(9):1270-4. PubMed ID: 1929956
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus.
Inomata H; Sakamoto T
Curr Eye Res; 1990; 9 Suppl():35-40. PubMed ID: 1974489
[TBL] [Abstract][Full Text] [Related]
3. Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site.
Okada T; Sakamoto T; Ishibashi T; Inomata H
Graefes Arch Clin Exp Ophthalmol; 1996 Jun; 234(6):359-63. PubMed ID: 8738701
[TBL] [Abstract][Full Text] [Related]
4. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
Inomata H; Rao NA
Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935
[TBL] [Abstract][Full Text] [Related]
5. Vogt-Koyanagi-Harada syndrome--isolation of cloned T cells with specificity for melanocytes and melanoma cells.
McClellan KA; MacDonald M; Hersey P; Billson FA
Aust N Z J Ophthalmol; 1989 Nov; 17(4):347-52. PubMed ID: 2624724
[TBL] [Abstract][Full Text] [Related]
6. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
7. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.
Abad S; Wieërs G; Colau D; Wildmann C; Delair E; Dhote R; Brézin AP; Kawakami Y; Coulie PG; van der Bruggen P
Mol Vis; 2014; 20():956-69. PubMed ID: 24991188
[TBL] [Abstract][Full Text] [Related]
8. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population.
Zhao M; Jiang Y; Abrahams IW
Arch Ophthalmol; 1991 Mar; 109(3):368-70. PubMed ID: 2003797
[TBL] [Abstract][Full Text] [Related]
9. Immunocytologic findings in a case of Vogt-Koyanagi-Harada syndrome.
Kahn M; Pepose JS; Green WR; Miller J; Foos RY
Ophthalmology; 1993 Aug; 100(8):1191-8. PubMed ID: 8341501
[TBL] [Abstract][Full Text] [Related]
10. Immunopathologic study of Vogt-Koyanagi-Harada syndrome.
Chan CC; Palestine AG; Kuwabara T; Nussenblatt RB
Am J Ophthalmol; 1988 Jun; 105(6):607-11. PubMed ID: 3259837
[TBL] [Abstract][Full Text] [Related]
11. [Involvement of Ia-positive accessory cells for activation of cytotoxic T lymphocyte specific for melanocyte-associated antigens in patients with Vogt-Koyanagi-Harada disease].
Maezawa N; Tsukahara S
Nippon Ganka Gakkai Zasshi; 1985 Mar; 89(3):440-6. PubMed ID: 3874531
[No Abstract] [Full Text] [Related]
12. Vogt-Koyanagi-Harada disease and HLA type in Italian patients.
Pivetti-Pezzi P; Accorinti M; Colabelli-Gisoldi RA; Pirraglia MP
Am J Ophthalmol; 1996 Dec; 122(6):889-91. PubMed ID: 8956647
[TBL] [Abstract][Full Text] [Related]
13. Vogt-Koyanagi-Harada disease in an adolescent boy.
Bilgiç Ö; Gündüz A; Kaya K
Pediatr Dermatol; 2014; 31(1):99-101. PubMed ID: 23869531
[TBL] [Abstract][Full Text] [Related]
14. Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome.
Zhang XY; Wang XM; Hu TS
Am J Ophthalmol; 1992 May; 113(5):567-72. PubMed ID: 1575232
[TBL] [Abstract][Full Text] [Related]
15. Choroidal thickness in convalescent vogt-koyanagi-harada disease.
Takahashi H; Takase H; Ishizuka A; Miyanaga M; Kawaguchi T; Ohno-Matsui K; Mochizuki M
Retina; 2014 Apr; 34(4):775-80. PubMed ID: 23979311
[TBL] [Abstract][Full Text] [Related]
16. [Incomplete Vogt-Koyanagi-Harada syndrome associated with HLA DRB1*01 in a 4-year-old child: case report].
Lucena DR; Paula JS; Silva GC; Rodrigues Mde L
Arq Bras Oftalmol; 2007; 70(2):340-2. PubMed ID: 17589710
[TBL] [Abstract][Full Text] [Related]
17. [Ocular infiltrating CD 4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens].
Sugita S
Nippon Ganka Gakkai Zasshi; 2008 Nov; 112(11):953-64. PubMed ID: 19069378
[TBL] [Abstract][Full Text] [Related]
18. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease.
Sugita S; Sagawa K; Mochizuki M; Shichijo S; Itoh K
Int Immunol; 1996 May; 8(5):799-803. PubMed ID: 8671669
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Vogt-Koyanagi-Harada disease.
Yamaki K; Gocho K; Sakuragi S
Int Ophthalmol Clin; 2002; 42(1):13-23. PubMed ID: 12189608
[No Abstract] [Full Text] [Related]
20. Clinicopathological and immunohistochemistry correlation in a case of Vogt-Koyanagi-Harada disease.
Das D; Boddepalli A; Biswas J
Indian J Ophthalmol; 2019 Jul; 67(7):1217-1219. PubMed ID: 31238472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
